risks of glp 1 drugs Long-Term Effects GLP-1 Medications: What You Should Know mapping the effectiveness and risks

The team identified elenolic acid -- a compound derived from oleuropein, which is abundant in olive fruit and EVOO -- as a direct stimulator of GLP-1 and PYY (peptide YY, another satiety hormone) release from gut L-cells

[DOI] [PMC free article] [PubMed] [Google Scholar] 215.Jayaprakasha G.K., Rao L.J

This structure allows semaglutide therapy to be integrated into broader health considerations rather than administered in isolation

Bonuses can look generous, yet their real value depends on the fine print

GLP-1R are expressed in both glomeruli and renal tubules, suggesting a direct effect on kidney function

Between January 2021 and May 2023, out of over 31,000 total adverse event reports for these three drugs, 372 included psychiatric events